EUVIMEDEUVIMED entdecken
Crossref

Simultaneously Enhancing NIR‐II Emission, Type‐I, and Type‐II Photosensitization Through Acceleration of Charge‐Separated‐State Formation for Tumor Phototheranostics

Yaru Lu, Yuchen Song, Yajing Jiang, Min Li, Zhengyumeng Zhu, Jucai Gao, Leilei Shi, Yu Tian, Dugang Chen, Duo Mao, Fang Hu, Wenbo Wu iD

Angewandte Chemie International Edition · 02.01.2026 · 65 (1)

DOI: 10.1002/anie.202521182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 06.11.2025. Verfasst von Yaru Lu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Institute of Molecular Aggregation Science, Tianjin University, Tianjin, 300072, P.R. China. Hauptthemen laut MEDLINE: Photosensitizing Agents, Antineoplastic Agents, Theranostic Nanomedicine. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phototheranostic agents with near‐infrared (NIR) excitation wavelengths offer significant promise for tumor imaging and therapy. However, due to the limitations imposed by the energy gap law, such agents tend to generate heat while exhibiting limited photosensitization effects and fluorescence intensity, which hampers their combination therapy efficacy. Herein, we present an effective strategy of “acceleration of charge‐separated‐state formation” to simultaneously enhance NIR‐II emission, type‐I and type‐II photosensitization efficiencies of NIR excitable phototheranostic agents. Specifically, following the optimization of the chemical structure and aggregated architecture, the rate of transition from localized excited (LE) state to charge‐separated (CS) state is improved from 1.19 × 10 9 s −1 (in toluene) and 2.65 × 10 11 s −1 (in water) for 8TP‐IF to 4.69 × 10 9 s −1 (in toluene) and 1.45 × 10 12 s −1 (in water) for 6TP‐IH. As a consequence, upon NIR 808 nm excitation, the fluorescence, •OH and 1 O 2 generation efficiencies of 6TP‐IH are improved to 15.6, 2.21, and 3.38 times to those of 8TP‐IF. Encapsulation of 6TP‐IH into nanoparticles (NPs) enables their application in NIR‐II fluorescence image‐guided tumor combination therapy. Both in vitro and in vivo studies confirm the precise tumor imaging capability of 6TP‐IH NPs, along with robust tumor ablation and effective activation of tumor immunogenic cell death (ICD) through synergistic photodynamic and photothermal therapy. These effects collectively yield an impressive tumor inhibition rate of 99.1% in a 4T1 tumor‐bearing mouse model.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Photosensitizing AgentsAntineoplastic AgentsTheranostic NanomedicineAnimalsMiceInfrared RaysHumansCell Line, TumorPhotochemotherapyOptical ImagingCell SurvivalFemale

Stichwörter der Autor:innen

Charge‐separated stateNIR‐II emissionPhotosensitizationPhototheranostic agentsPhototherapy

Substanzen

Photosensitizing AgentsAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Chemistry, Institute of Molecular Aggregation Science, Tianjin University, Tianjin, 300072, P.R. China.
  • Biomaterials Research Center, School of Biomedical Engineering, Guangdong Provincial Key Laboratory of Medial Image Processing, Southern Medical University, Guangzhou, 510515, P.R. China.
  • Institute of Precision Medicine, The First Affiliated Hospital of Sun Yat-Sen University, Sun Yat-Sen University, Guangzhou, 510080, P.R. China.
  • Precision Research Center for Refractory Diseases in Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200025, P.R. China.
  • Key Laboratory for Green Chemical Process of Ministry of Education, School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan, 430205, P.R. China.
  • State Key Laboratory of Advanced Materials for Intelligent Sensing, Tianjin University, Tianjin, 300072, P.R. China.

ORCID-Profile: Wenbo Wu

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Lu, Y., Song, Y., Jiang, Y., Li, M., Zhu, Z., Gao, J., Shi, L., Tian, Y., Chen, D., Mao, D., Hu, F., & Wu, W. (2026). Simultaneously Enhancing NIR‐II Emission, Type‐I, and Type‐II Photosensitization Through Acceleration of Charge‐Separated‐State Formation for Tumor Phototheranostics. Angewandte Chemie International Edition, 65(1). https://doi.org/10.1002/anie.202521182

Vancouver

Lu Y, Song Y, Jiang Y, Li M, Zhu Z, Gao J, et al. Simultaneously Enhancing NIR‐II Emission, Type‐I, and Type‐II Photosensitization Through Acceleration of Charge‐Separated‐State Formation for Tumor Phototheranostics. Angewandte Chemie International Edition. 2026;65(1). doi:10.1002/anie.202521182

BibTeX
@article{Lu2026,
  author = {Lu, Yaru and Song, Yuchen and Jiang, Yajing and Li, Min and Zhu, Zhengyumeng and Gao, Jucai and Shi, Leilei and Tian, Yu and Chen, Dugang and Mao, Duo and Hu, Fang and Wu, Wenbo},
  title = {Simultaneously Enhancing NIR‐II Emission, Type‐I, and Type‐II Photosensitization Through Acceleration of Charge‐Separated‐State Formation for Tumor Phototheranostics},
  journal = {Angewandte Chemie International Edition},
  year = {2026},
  volume = {65},
  number = {1},
  doi = {10.1002/anie.202521182}
}
Kostenlos starten →